The Speaker, Ekiti State House of Assembly, Adeoye Aribasoye, has decried the low participation of women in politics, ...
The Ekiti State House of Assembly Speaker, Adeoye Aribasoye, has expressed concern over the minimal involvement of women in Nigerian politics, emphasizing ...
Tribune Online on MSN4d
Legislative, political institutions should create opportunities for women — Ekiti speakerThe speaker of the Ekiti State House of Assembly, Adeoye Aribasoye, has called on political and legislative institutions in the country to create more opportunities for women.While lamenting the low ...
Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.
FOSTER CITY, Calif. - Gilead Sciences, Inc. (NASDAQ:GILD), a prominent player in the biotechnology industry with a market capitalization of $142 billion and annual revenue of $28.75 billion ...
Gilead (GILD) stock in focus as its HIV anti-viral lenacapavir shows promise in HIV prevention with once-yearly PrEP ...
Once-Daily Orals and In-Depth Look at Adolescent Pharmacokinetic, Safety and Efficacy Data – "Gilead is continuing to innovate in our work to develop additional person-centered long-acting ...
Last year, Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against infection with just a single injection every six months.
FOSTER CITY, Calif. - Gilead Sciences, Inc. (NASDAQ:GILD), a prominent player in the biotechnology industry with a market capitalization of $142 billion and annual revenue of $28.75 billion, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback